biotechrabbit is determined to offer the best products and services to those who lead the way in research. The valued relationships with our partners and customers drive us to exceed current limitations with flexibility, innovation and highly customized solutions to match their specific requirements. Each member of our team of highly engaged scientists, experienced managers and talented business developers aims to facilitate our partners and customers to leap and lead progress in the life science. Covering the whole workflow from enzyme production, ReadyMix development and lyophilization, biotechrabbit is the partner of choice for supplying molecular biology enzymes, reagents and mixes to diagnostics and life sciences. Our way of doing business combines the passion and pure curiosity of excellent researchers with the agile spirit of true entrepreneurs. | Covering the whole workflow from enzyme production, ReadyMix development and lyophilization, biotechrabbit is the partner of choice for supplying molecular biology enzymes, reagents and mixes to diagnostics and life sciences. biotechrabbit is determined to offer the best products and services to those who lead the way in research. The valued relationships with our partners and customers drive us to exceed current limitations with flexibility, innovation and highly customized solutions to match their specific requirements. Each member of our team of highly engaged scientists, experienced managers and talented business developers aims to facilitate our partners and customers to leap and lead progress in the life science. Our way of doing business combines the passion and pure curiosity of excellent researchers with the agile spirit of true entrepreneurs.
BIOTECHNOLOGY VALLEY
The Biotechnology Industrialists’ Association (BİYOSAD) aims to drive human development via innovative, high value-added products and services and is establishing the Biotechnology Valley within the Biotechnology Specialized Industrial Zone (BİOSB) in Istanbul. This project aspires to situate Turkey among the world’s leading biotechnology hubs. Biotechnology Valley, positioned in strategically located Tuzla, Istanbul, is a comprehensive initiative designed to create a specialized biotechnology ecosystem. The project aims to boost Turkey’s global presence in the biotechnology market through strong collaborations between business, academia, and the government. It spans 2.7 million square meters and will feature technology development zones, R&D centers, testing and calibration labs, patent offices, and specialized biotechnology schools. Our goal is to enhance global export potential by fostering domestic production of high value-added biotechnology products. We prioritize guiding industry and academia toward innovative collaboration, exploring nature’s possibilities in light of science. Our mission extends beyond meeting current demands to making a positive impact for future generations through sustainable and collaborative efforts. Biotechnology Valley is dedicated to enabling breakthrough technologies in the sector and hosting research that benefits society, adding value to both science and business. We are committed to providing a safe, innovative, and supportive business environment for all sector stakeholders. Join us as a partner in transforming Türkiye and the world into a leading biotechnology center. | Biotechnology Valley is a strategic technology and innovation ecosystem established under the leadership of the Biotechnology Industrialists Association (BIYOSAD) to lead Türkiye’s vision in biotechnology across science, technology, and production. Bringing together the public sector, industry, academia, and investors, the Valley aims to build a high–value-added, sustainable, and globally competitive biotechnology infrastructure. Located in Tepeören, Istanbul, and spanning approximately 2.7 million square meters, Biotechnology Valley is one of Türkiye’s most comprehensive biotechnology initiatives. With its advanced R&D centers, technology development zones, modern manufacturing facilities, and shared infrastructure, the Valley is designed as an integrated hub for local and international companies operating in pharmaceuticals, biotechnology products, medical technologies, and advanced life sciences. Biotechnology Valley is not only a center for production and R&D, but also a living and innovation ecosystem with sustainability at its core. The project prioritizes energy-efficient infrastructure, renewable energy solutions, water efficiency practices, integrated waste management systems, and comprehensive strategies to reduce carbon footprint. This approach positions biotechnology production in harmony with nature and with a strong sense of responsibility toward future generations. The Valley offers a collaborative, innovative, and scalable ecosystem for a wide range of stakeholders, from start-ups and research institutions to global players and investment funds. Through its open innovation approach, Biotechnology Valley promotes knowledge sharing and co-creation, aiming to integrate Türkiye’s biotechnology potential into the global value chain. With its robust infrastructure, sustainability-driven framework, and international vision, Biotechnology Valley continues to advance with determination toward becoming a regional and global center for biotechnology.
BIOSYNTH
Securing Life Sciences Supply Chains – where Chemistry meets Biology, Products meet Services and Innovation meets Quality, Biosynth is at the Edge of Innovation. With an unrivalled research product portfolio of over a million products and end-to-end manufacturing services, we are science led and customer-focused to solve problems, taking pride in delivering products and projects that others cannot. Our expertise and capabilities run across Complex Chemicals, Peptides and Key Biologics all from one trusted partner. Supplying the pharmaceutical, life science and diagnostic sectors, along with customers across food, agrochemistry and cosmetics, we have facilities across three continents and a rapid global distribution network. We produce chemicals on the milligram to ton scale, and at ISO 9001 and GMP, with peptides at mg to multikilogram scale. | Critical Raw Materials and Services for Diagnostics, Vaccines and Pharmaceuticals – where Chemistry meets Biology, Products meet Services and Innovation meets Quality, Biosynth is at the Edge of Innovation. With an unrivalled research product portfolio of over a million products and end-to-end manufacturing services, we are science led and customer-focused to solve problems, taking pride in delivering products and projects that others cannot. Our expertise and capabilities run across Complex Chemicals, Peptides and Key Biologics all from one trusted partner. Supplying the pharmaceutical, life science and diagnostic sectors, along with customers across food, agrochemistry and cosmetics, we have facilities across three continents and a rapid global distribution network. We produce chemicals on the milligram to ton scale, and at ISO 9001 and GMP, with peptides at mg to multikilogram scale. Find out more at www.biosynth.com. | Securing Life Sciences Supply Chains – where Chemistry meets Biology, Products meet Services and Innovation meets Quality, Biosynth is at the Edge of Innovation. With an unrivalled research product portfolio and end-to-end manufacturing services, we are science led and customer focused to solve problems and deliver key reagents at scale and quality. Our expertise and capability runs across Complex Chemicals, Peptides and Key Biologics all from one trusted partner. Biosynth is an innovative life sciences reagents, custom synthesis and manufacturing services company. We are by scientists, for scientists, securing supply chains with consistent quality, across the globe. We manufacture and source a vast range of chemical and biochemical products, and take pride in delivering products that others cannot. We are experts in complex chemistry, peptides and key biological raw materials. We provide a full range of products and services to support life science research and development, with more than half a million products in our research catalog and hundreds of complex manufacturing service projects. Our complex chemistry specialties include enzyme substrates, carbohydrate and nucleoside chemistry, with manufacturing services from the first idea to the finished product, from route scouting to GMP or ton scale production. For peptides, we also have a full end-to-end offering, from lead discovery and optimization, library production, through to GMP NCE or Neoantigen projects. Across biologics we have a synergistic offering, with an extensive range of custom bioprocessing enzyme projects for production of key products. We are also able to offer custom antibody projects, and epitope mapping. Through the Biosynth group we also offer development of antibodies, antigens and supply of plasma for in vitro diagnostics. The trusted supplier, manufacturer and partner for the pharmaceutical, life science and diagnostic sectors, along with customers across food, agrochemistry and cosmetics, we have facilities across three continents and a rapid global distribution network. Our main chemical research and manufacturing laboratories are in Switzerland, the United Kingdom, Slovakia and China, with peptide production in the USA and the Netherlands. Enzyme projects are based in Austria and biological IVD reagents in Ireland. Our R&D resources and production facilities are modern and versatile, allowing us to produce chemicals on the milligram to ton scale, and at ISO 9001 and GMP, with peptides at mg to multikilogram scale.
BioProduction by SEKISUI
BioProduction by Sekisui offers CDMO services for the biopharmaceutical industry. Our UK facility has over 40 years fermentation and purification experience with proteins. Our microbial expression and process optimization together with our production experience helps smooth technical transfer and process scale up. We have process and analytical development capabilities for enzymes, plasmids, antibody fragments and other proteins. We are completing a $19M cGMP manufacturing expansion for drug substance manufacturing in 2024. We are co-exhibiting with Sekisui America Corporation, the regional HQ of global chemical manufacturer Sekisui Chemical, located in the United States. They work on developing solutions for the life science industry, with a focus on cell and gene therapy. Products include cell culture consumables such as state-of-the-art cell culture media and scaffolds. Chemically defined scaffold (CDS) can be used for the serum-free culture of pluripotent stem cells (iPSCs, ESCs, MSCs and so on). It is a synthetic polymer that can be stored at room temperature, pre-coated on a variety of surfaces and can be adapted to automated culture equipment. It can establish a safe and stable cell culture process and can lead to reduction in total cell culture cost. We are looking for partners in the field of cell and gene therapy such as academic organizations, pharmaceutical companies and automated bioreactor manufacturers who can act as joint development partners in adapting our products for their pipeline. | BioProduction by SEKISUI – A Specialized CDMO within the SEKISUI Medical Group BioProduction by SEKISUI is the biomanufacturing CDMO division of SEKISUI Diagnostics, part of the globally recognized SEKISUI Medical Group.BioProduction by SEKISUI describes SEKISUI’s contract service offering as a microbial fermentation focused CDMO with over 40 years of expertise in microbial biomanufacturing. We specialize in microbial fermentation, protein purification, and downstream processing for enzymes, recombinant proteins, ligands, antibody fragments, and plasmids. With experience in E. coli, Pichia pastoris, Bacillus, Streptococcus, Streptomyces, fungi, and yeast, we provide seamless process transfer and scale-up to meet diverse biopharmaceutical needs. Our UK-based facility features fermentation capacities ranging from 2L to 5,000L, advanced chromatography techniques, and lyophilization capabilities. While cGMP capacity expansion for clinical-grade drug substance manufacturing is in progress, we adhere to ISO 9001 standards, ISO 8 cleanroom classifications, and environmental safety regulations, ensuring quality and reliability. Driven by Kaizen-based continuous improvement and a zero-emissions sustainability commitment, BioProduction by SEKISUI partners with global leaders to deliver scalable, high-quality biomanufacturing solutions. Learn more at bioproduction-sekisui.com. SEKISUI CHEMICAL Group has been driving innovation since 1947. Today, we’re committed to developing cell culture solutions that make cell culture more reliable, scalable, and efficient. Our flagship product, Ceglu™, is a chemically defined, synthetic matrix that provides a stable, feeder-free environment for stem cells (iPSCs, ESCs, MSCs). Designed for consistency and ease of use, Ceglu™ reduces variability and offers the convenience of room-temperature storage. Ceglu™ is available in two formats: pre-coated culture plates for immediate use and a coating solution that can be applied to automated culture systems and bioreactors for seamless large-scale production. With a focus on advancing regenerative medicine, SEKISUI collaborates with industry leaders to deliver innovative solutions that meet the evolving needs of the cell and gene therapy field and help achieve shared goals. Learn more at https://www.sekisui-cell.jp/en/
Bionova Scientific
Based in Fremont, California, Bionova Scientific is a rapidly growing biologics CDMO offering world-class services built on a foundation of strong process development and analytical science. Our team shares decades of experience in late stage and commercial launch projects, specializing in mammalian cell culture production of mAbs, bispecifics, fusion proteins and other recombinant proteins. We operate a brand-new commercial-ready GMP biologics manufacturing facility to provide clinical and commercial production for clients and recently initiated an expansion program that will quadruple our GMP manufacturing capacity. We are currently booking slots for 2023 and beyond. Our upstream PD group, with more than 60 benchtop bioreactors, offers capabilities typically found in CDMOs five times our size. | Bionova Scientific is an Asahi Kasei company based in Fremont, California. Bionova Scientific is a full-service biologics CDMO offering world-class services built on a foundation of strong process development, cell line development and analytical science. Our team shares decades of experience in late stage and commercial launch projects, specializing in mammalian cell culture production of mAbs, bispecifics, fusion proteins and other recombinant proteins. We operate a brand-new commercial-ready GMP biologics manufacturing facility to provide clinical and commercial production for clients and recently initiated an expansion program that will quadruple our GMP manufacturing capacity. Our upstream PD group, with more than 60 benchtop bioreactors, as well as the ambr15 and ambr250 platforms offering capabilities typically found in CDMOs five times our size. | Bionova Scientific is a flexible, fast-moving CDMO focused on recombinant protein therapeutics and plasmid DNA. With a strong foundation in cell line development, process development and analytical sciences, we operate a brand-new commercial-ready GMP biologics manufacturing facility to provide clinical and commercial production for clients (with additional expansion underway). Our team shares decades of experience in late stage and commercial launch projects, specializing in mammalian cell culture production of complex recombinant proteins, including mAbs, multispecifics, and fusion proteins. Bionova Scientific is an Asahi Kasei company. | Bionova Scientific is a bespoke CDMO providing end-to-end development and GMP manufacturing services for recombinant proteins and plasmid DNA. We support biotherapeutic programs at any stage, from cell line development through commercial-ready manufacturing. Protein operations are based in Fremont, California, with a dedicated plasmid DNA facility in Houston, Texas offering plasmid design through GMP production. Founded in 2014 and acquired by Asahi Kasei in 2022, Bionova combines CDMO agility with the global resources and financial strength of a leading bioprocessing organization.
BIONOVIS SA – COMPANHIA BRASILEIRA DE BIOTECNOLOGIA FARMACEUTICA
Bionovis is a Brazilian pharmaceutical biotechnology company whose objective is to promote the research & development, manufacturing, distribution, and commercialization of highly complex biopharmaceuticals. We constantly invest in highly qualified human resources and in the acquisition of equipment and technology. This structure allows us to fully produce several innovative biological, biosimilar and biopharmaceutical medicines for the treatment of various pathologies, increasing access to high-technology medicines for patients. In more than a decade of operation, we have built partnerships with major global leaders in the biopharmaceutical sector. Through these partnerships, we receive the complete technology to produce innovative biopharmaceuticals and biosimilars. In our history, we have already positively impacted around 1 million patients, through the provision of more than 16 million vials and syringes of biopharmaceuticals. We are committed to ensuring Brazil’s self-sufficiency in the development and manufacturing of high-quality, highly complex biological products, increasingly expanding the access of Brazilians to these medicines. Aligned with global standards and requirements required of the National Health Surveillance Agency – ANVISA (approved in November 2023 – API and December 2024 – Fill and Finish), regulatory agencies in the United States (Food and Drug Administration – FDA – expected for 2027) and Europe (European Medicines Agency – EMA – expected for 2027). Bionovis is looking for opportunities to license biological and biosimilar products for the Brazilian market and offers C(D)MO capabilities for Brazil and Latin America.
Biogénesis Bagó S.A.
We are a biotechnology company specialized in the development, production and commercialization of solutions for animal and environmental health. We aim to collaborate in strengthening the sanitary status of each country, fostering new productive developments, and ensuring animal, human and environmental welfare. Our products are present in over 60 countries in America, Asia, Europe, the Middle East, North Africa and Oceania. We are a team of +1000 collaborators worldwide, with a modern management that integrates multiple nationalities. We are supported by our background and constant evolution. We are driven by an inquisitive spirit in the pursuit of anticipating and thinking innovative solutions for animal health issues, through different business models. We work with various international institutions to achieve innovative solutions that allow us to properly address the specific animal health needs of each context. We have a top-notch professional technical service that supports and assists producers and veterinarians to apply technologies correctly. By means of our knowledge and experience, we contribute to improve productivity rates and animal care. At Biogénesis Bagó we work aligned with the concept of “One Health”, which establishes that “human health and animal health are interdependent and linked to the ecosystem in which they coexist” We are committed to the prevention, control and elimination of zoonoses in different regions of the world. We are continuously working on prevention programs through the use of safe, effective, and quality vaccines, thus providing health to all species we focus on. Our vaccine against foot-and-mouth disease is recognized as a world-class product that meets the highest quality standards, validated by the most demanding health authorities. We are one of the main providers of anti-rabies, canine and feline, vaccines for organizations that attend public health campaigns.
Biodextris
Biodextris is a CDMO within the vaccines and biologics industries providing pre-clinical and clinical manufacturing, process development services and analytical services for method development, release testing and stability testing. Our experienced biologics scientists and key team members have worked together in medium to large vaccine development and manufacturing companies for almost twenty years. Biodextris team provides its extensive biopharmaceutical expertise in an adapted, flexible and interactive setting to clients of various sizes. We develop, manufacture and test a wide range of complex biological products (including mammalian, insect, yeast and bacterial based production) such as adjuvants, proteins, antibodies, etc. for vaccine or other pharmaceutical applications. Biodextris has the big pharma experience and expertise to develop high-quality, robust, and marketable products, while acting with the flexibility and sense of urgency required by small organizations. | Biodextris is a Contract Development and Manufacturing Organization located near Montreal focused on complex biologics from discovery through late-stage clinical development. Our services cover bioprocess development, analytical development, manufacturing of pre-clinical material, GMP Manufacturing (downstream and upstream) of clinical material, Quality Control release and stability testing and small batch size fill finish in vials. We are working with all types of host cell systems (microbial, mammalian, insect cells, yeast, plant and algae) to produced vaccines, monoclonal antibodies, therapeutic recombinant proteins, whole cell therapeutics, AMR products, plasmids and other related complex biologics. The company is staffed by experienced biologics development scientists, and key team members have worked together in medium and large vaccine development and manufacturing companies for almost twenty years. Our experience in both biotech and big pharma settings is one of our key competitive advantages. We apply an integrated approach to early-phase development to reduce timelines and have the expertise and procedural systems necessary to ensure regulatory compliance for clinical or commercial products. The Biodextris team provides its extensive pharmaceutical expertise in an adapted and interactive setting to clients of various sizes. Biodextris has the experience and expertise to develop high-quality, robust, and marketable products, while acting with the flexibility and sense of urgency required by small organizations.